Tenders of Dak Gesundheit

Germany-hamburg: Pharmaceutical Products

Completion of a non-exclusive discount agreement According to § 130a para. 8 Sgb W To the active ingredient Permethrin, Atc P03ac04 For The Time 01.07.2023 - 30.06.2025 (1003956 - Permethrin, Atc P03ac04)

Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient milnacipran, ATC N06ax17 (obg) for the period 01.09.2024 - 31.08.2026

Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 Sgb V for the active ingredient formoterol, beclometasone, glycopyrronium, Atc R03al09 for the period November 1st, 2023 - October 31st, 2025

Germany – Pharmaceutical Products – Abschluss Einer Nicht-exklusiven Rabattvereinbarung Nach § 130a Absatz 8 Sgb V Zum Wirkstoff Amlodipin + Hct + Ramipril, Atc C09bx03 Für Die Zeit 01.02.2024 - 31.01.2026

Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 Sgb V for the active ingredient Natalizumab (exclusively in the Dafo infusion solution concentrate), Atc L04aa23 for the period December 1st, 2023-November 30th, 2025 (1004084 - Natalizumab (exclusively in the kiln

Germany-hamburg: Pharmaceutical Products

Germany-hamburg: Pharmaceutical Products

Conclusion of a non-exclusive discount agreement according to Section 130a Paragraph 8 Sgb V for the active ingredient Enoxaparin (only individual potency-standard size combinations), Atc B01ab05 for the period 01.11.23 - 31.10.25 (1004064 - Enoxaparin (only single potency-no

Germany-hamburg: Pharmaceutical Products